The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects
media
posted on 2020-06-11, 08:49 authored by Masaomi Takizawa, Dirk Cerneus, Ingrid Michon, Sanne Rijnders, Desiree van der Heide, John Meijer, Matthias Stoelzel, Yuichiro Sato<p><strong>Article full
text</strong></p>
<p> </p>
<p><br></p><p><br></p>
<p> </p>
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2020.</p>
